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Progress toward understanding the function and regulation of noncoding RNAs is the topic of this issue’s Molecular
Biology Select. Recent reports provide mechanistic insight into the regulation of transcription by noncoding RNAs found
at gene promoters. Other findings reveal a new mechanism for the regulation of attenuated noncoding transcripts,
provide evidence for the involvement an antisense transcript in Alzheimer’s disease, and shed light on the evolutionary
conservation of imprinting mechanisms in mammals.
Noncoding RNAs Build a Bridge to Transcription’s
End
Cyclin D1 is a cell cycle regulator that is repressed by DNA damage to prevent cell cy-
cle progression while DNA lesions are being repaired.Wang et al. (2008) have recently
shown that DNA damage signals enhance the expression of noncoding RNAs that are
tethered to the 50 regulatory region of the cyclin D1 gene. These noncoding RNAs
recruit the RNA binding protein translocated in liposarcoma (TLS), which in turn binds
and inhibits the histone acetyltransferases CREB-binding protein (CBP) and p300.
The resulting suppression of local histone acetylation inhibits cyclin D1 transcription.
Remarkably, this entire process is RNAdependent, indicating that the noncoding RNA
is an allosteric regulator of TLS. These findings reveal a new means by which tran-
scription can be regulated in response to cellular signals and a new function for non-
coding RNAs. Future efforts will determine the chain of signals that link DNA damage
to the expression of the noncoding RNAs and may reveal whether noncoding RNAs
are expressed in the 50 regulatory regions of other genes whose expression is
repressed by DNA damage signals.
X. Wang et al. (2008). Nature 454, 126–130.
A Hidden Meaning behind a Pol II Initiation Ritual
For some genes, the selection of the start site of transcription is an important feature of their regulation, with some start sites
leading to attenuated transcripts that are targeted for degradation. Kuehner and Brow (2008) now show that the concentration
of nucleotides can regulate which transcription start site is selected by RNA polymerase II (pol II). Although the potential func-
tional consequences of this type of regulation are numerous, the example provided by the authors is a compelling one.They
studied transcription of the yeast gene inosine monophosphate dehydrogenase 2 (IMD2), which encodes a key enzyme in
guanosine triphosphate (GTP) biosynthesis. They observe that when the GTP concentration is high, upstream guanines
are favored as the start sites for transcription. This leads to the production of attenuated noncoding transcripts because of
the presence of a terminator sequence recognized by the helicase Sen-1 via its associated RNA-binding proteins. When
GTP levels are low, this terminator sequence is bypassed, and pol II instead chooses a downstream adenine as the start
site. This leads to transcription through the coding region of the IMD2 gene, enhanced Imd2 protein expression, and GTP
biosynthesis. The new study uncovers a clever means by which the cell maintains nucleotide homeostasis. The authors
also provide evidence that the effect of nucleotide concentration appears to be mediated through the Rpb1 subunit of
pol II. Whether other genes are similarly regulated by nucleotide concentration or whether this pathway is present in other
organisms awaits further exploration.
J.N. Kuehner and D.A. Brow (2008). Mol. Cell 31, 201–211.
Making Sense of Antisense
Previous work has indicated that synthetic small interfering RNAs directed to promoters can alter gene expression in mam-
malian cells. Argonaute proteins may be involved in this process. However, given that complexes of Argonautes and small
RNAs normally bind to target mRNA sequences, it has been unclear how the Argonautes would be targeted to a region of
a gene that is not known to be transcribed. In their recent work, Schwartz et al. (2008) report data that may reconcile these
results. By examining transcription at the progesterone receptor gene locus in cultured human cancer cells, the authors un-
covered the existence of endogenous antisense transcripts that overlap with the promoter region of the gene. They show that
the synthetic small RNAs are recruited to the gene promoter through the recognition of the antisense transcript and that a
decrease in the expression of the antisense transcript impairs the ability of promoter-directed small RNAs to alter expression
of the progesterone receptor gene. For small RNAs that activate gene expression, their recruitment to the promoter shifts the
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localization of heterogeneous nuclear ribonucleoprotein K (hnRNP-k) fromDNA toRNA and leads to a decrease in heterochro-
matin protein 1g (HP1g) at the promoter. Homologs of HP1g in yeast are integral to RNA-induced transcriptional silencing
(RITS), and future work may further characterize the similarities and differences between RITS and the action of synthetic
promoter-directed small RNAs. It is also an open question as to whether endogenous small RNAs in mammalian cells, rather
than synthetic RNAs, might be found that similarly target promoter sequences.
J.C. Schwartz et al. (2008). Nat. Struct. Mol. Biol. Published online July 6, 2008. 10.1038/nsmb.1444.
InAlzheimer’sDisease,BACE IsMistuned
The protease BACE1 (also known as b-Secretase) is involved in the
processing of amyloid precursor protein and is critical for genera-
tion of the Ab1-42 peptide implicated in the pathogenesis of
Alzheimer’s disease. Faghihi et al. (2008) now provide evidence
that BACE1 expression is regulated by an endogenous BACE1 an-
tisense transcript. The antisense transcript encompasses a large
segment of the BACE1 locus, and, like the sense transcript, it is
spliced and polyadenylated, yet no coding region can be found
within it. Interestingly, knockdown of the antisense transcript in cul-
tured human cell lines and the brain of living mice with short inter-
fering RNAs led to a simultaneous decrease in the expression of
the sense transcript, suggesting that the antisense transcript is
a positive regulator of BACE1 expression. Likewise, knockdown
of the antisense transcript also decreased the production of Ab
peptide in human embryonic kidney cells bearing a mutation in
the amyloid precursor protein that has been linked to early-onset
Alzheimer’s disease. The authors show that the sense and anti-
sense transcript can form a duplex that stabilizes the sense tran-
script. They also show that the antisense transcript is elevated in
the brains of Alzheimer’s disease patients, suggesting a possible involvement in disease pathogenesis. Future work might
further explore how the expression of the antisense transcript is regulated longitudinally in vivo. As a step in this direction,
the authors show that environmental stressors, such as serum deprivation or high temperatures, can elevate the expression
of the antisense transcript in cultured cells.
M.A. Faghihi et al. (2008). Nat. Med. 14, 723–730.
H19 Noncoding RNA Leaves a Lasting Evolutionary
Imprint
Genomic imprintingensures theexpressionofacopyofagene inamanner specifiedby
theparent of origin. As a topic ofmajor interest in humanbiology, it isworth considering
the fact that genomic imprinting is not universal among animals, and, given its potential
absence from monotremes, it may not even be a shared feature of all mammals. New
work by Smits et al. (2008) sheds light on the evolution of genomic imprinting through
the identificationof an imprinted locus for a noncodingRNA that is sharedbetweenpla-
cental mammals and marsupials. Previous efforts have only identified a handful of
genes that are imprinted in both marsupials and placental mammals, and evidence
suggested that the mechanisms of imprinting might be poorly conserved. Despite low sequence similarity, the authors were
aided in their search for themarsupial homolog of theH19 gene (known to be imprinted in placental mammals) by several char-
acteristics. These include the proximity of H19 to another imprinted locus (that of the IGF2 gene), a shared exon structure with
theH19geneofplacentalmammals, and theconservationof amicroRNA (miR-675) in exon1. Inplacentalmammals,H19 is only
expressed from thematernal locus, and the same was shown to be true in tissues from young wallabies (still in the pouch). The
authors also show that the paternal copy of wallabyH19 ismethylated upstreamof the gene in a region containing binding sites
for CTCF, a protein that insulates promoters from the effects of distant enhancers. In placental mammals, CTCF is the master
regulator of imprinting in the H19-IGF2 region, suggesting that the overall mechanism of imprinting is conserved between pla-
cental mammals andmarsupials. Looking forward, it will be interesting to determine whether any of these elements of genomic
imprinting are found in themore distantly relatedmonotremes. Also, identifying the targets ofmiR-675 that are shared between
marsupials and placental mammals might reveal reasons behind the conservation of this noncoding RNA.
G. Smits et al. (2008). Nat. Genet. Published online June 29, 2008. 10.1038/ng.168.
Robert P. Kruger
Proposed role of the BACE1 antisense transcript (BACE1-AS)
in plaque buildup in Alzheimer’s disease. Figure courtesy of
C. Wahlestedt.
A tammar wallaby with a large pouch
young. Photo courtesy of G. Shaw.Cell 134, July 25, 2008 ª2008 Elsevier Inc. 197
